Jan 31st 2021

New recommendations :

American Shared Hospital Services (AMS) $ 2.50

www.ashs.com

presentation : https://ashs.com/wp-content/uploads/2019/10/ASHS-Investor-Presentation-September-2019-Final2.pdf

AMS provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is a world leader in providing Gamma knife radiosurgery equipment , a non-invasive treatment for malignant and benign brain tumors, vascular malformations, and trigeminal neuralgia (facial pain). The company also offers proton therapy, and the latest IGRT, IMRT and MR/LINAC systems.

As of Nov 2, 2020~ 5.7 million shares outstanding

40% owned by insiders

Recently Insiders have buyers during early Jan 2021~ bullish

Buyout potential as consolidation of industrial segment

cash/share ~.63

book value~ $5.38

9 months rev $13.2 million vs $$16 million, (.14) vs .08

Because of the lack of regular hospital services, revenues have slid. We believe as vaccines become more and more readily available hospital services will return to normal and even get a burst because of patient delay. This all points to large revenue and the return to profitability . Of course the Covid19 ( real name Wuhan virus)- because of PC we call it Covid19 even though China created it in the lab in our opinion.

The insiders know this and have been buying!

As the Robinhood herd scour the stock landscape it is eventual that AMS will be found and a stock price burst will occur!

AMS offers traders the option of a scalp or for long term investor types the long term appreciation potential from either organic growth, acquisition or buyout!

AMS is a cheap stock and could easily be worth 2-3X the current share price.

****************************************************

****************************************************

9meters Biopharma (NMRT) $1.38

http://www.9meters.com

The company is a focused gastroenterology company.

The company is advancing NM-002, a proprietary long-acting GLP- agonist into a Phase

2 trial for short bowel syndrome (SBS), a rare, orphan disease, as well as Larazotide, a Phase 3 tight junction regulator being evaluated for patient -reported symptom improvement in non-responsive Celia disease. Market for Celiac by 2023 anticipated to grow to $661 million.

Dec 21. 2020 NMTR and EBRIS form agreement to evaluate Larazotide for Covid-19

Respiratory complications.

Dec 15, 2020 NMTR completed a common stock offering and raised $34 million.

Insider buying has been heavy ~ bullish

presentation~ https://9meters.com/wp-content/uploads/2020/12/9M_CorporatePresentation.pdf

fully diluted shares outstanding 210 million

52 week range ~.37-$1.77

Pipeline ~5 programs

150 patents

6 analysts are following

recently Oppenheimer placed a $6 near term target!

Biotech investments are a different kind of pony! Money, timing and success are the ingredients for a success story in this humongous industrial segment. We have been successful with ARWR @ $2.00 currently $77 and CVM @ $1.35 now $25.00. Both of these are not overnight success stories, but take years. Buyouts are not uncommon!

The big fish eat the little fish. The pony becomes the unicorn and everyone has a happy ending!

With this surge of neophyte investor types that are busting at the seams and have become a force in moving stocks at any moment in time, NMRT could "rocket ship"!

Just look at GME. AMC, BB, NOK, JAN, BBBY and many others.

Zero interest rates have created serious bubbles everywhere! The housing bubble, the Bitcoin massive bubble, the stock market bubble ( free trades and everyone is now a day trader)

Bottomline: NMTR in this market environment has plenty of opportunity for investors to

profit from successful Phase studies, herd buying and even a buyout! As a cash rich junior biotech better to be in than out!

+++++++++++++++++++++++++++

+++++++++++++++++++++++++++

Biden success story with 1449 days left!

Free abortions worldwide and American taxpayers pay the bill.

Shutting down the O&G business so we can become dependent on foreign oil again! (John Kerry -total fool that looks horrible says we will build windmills in the USA! John we have not built windmills for over 10 years! China does panels and windmills. Rejoin the Paris Climate Accord~ put the USA out of business but aid China.)

Transgender women can compete with all women in sports! That is the end of women sports as we know it!

Transgenders are now back in the military! Personnel have to deal with bullets flying and transgender men, transgender women, non-binary, binary, A-sexual and homosexual! GOT ALL OF THAT?

We will allow the Caravans from Central America to "come on in MAN"- it is now an "open door" policy!

Let me get this straight! We will kill as many babies as possible, but if you are lucky enough to survive the birthing ceremony you are welcome into the USA!

Here comes the Iran Nuclear deal 2.0- How much money are we going to give them now! What penalty will we face because Trump was such a "bad man"?

It has only been 11 days and feels like 4 years. Sorry, we have to impeach Trump for the second time or is it the third?

GOD help us!

Final bits:

Take a look @ EcoHealth Alliance and Doctor Faucci. How much money did we aid in the Wuhan Lab funding of the Horseshoe bat virus? Over 2 million people that we know of have died from this cover-up.

Gamestock GME ~At $325.00 per share valuation there is going to be severe pain sooner than later. Looking at the 3rd Q results you have to wonder why anyone in their right mind would buy this stock when the fundamental look questionable. You have a stated book value of $4.74 and mounds of debt and continual losses.. Sure they had $660 million in cash, but they lost all most $300 million for the 9 months. The savior for the company near term is that they are going to raise a "pot" of money any day and that may change the longevity and possible growth because of their war chest! We see little chance that GME is going to stay at these lofty levels. The market cap is a chilling @ $22.7 billion and other Robinhood plays are equally dangerous.

The "shorts" basically got slaughtered and 100% of the herd is happy. Many times over the past decade they have destroyed countless investment opportunities because the company was driven into the ground. The first and second step that is needed by the Biden administration ( most likely never happen) is bring back the "up-tick rule concerning "shorting" and stronger penalties for "naked" shorting! Trump should have done it just like Obama missed the chance and Biden does not have the "balls" to even think about it!

LASTLY- WATCH FOR A NEW ENTRY POINT TO GET BACK INTO( JAN) AFTER GETTING OUT @ $27.00 NOW $9.00. COMPANY RAISE HAPPENING, BUT SHARE PRICE COULD GET BACK TO THE $6.00-$700 ! MARKET CONDITION COULD ALSO PLAY A ROLE IN SHARE PRICE.

Happy Investing!

If you want to be informed about our next stock recommendation before the herd send us a check for $99.00 with you phone number/text and you get to buy first!

S,A, Advisory

4708 S Holladay Blvd

S L C Utah 84117

questions 949 922 9986

Brief: January 28, 2021

Recommended JAN @ $3.66 via Nov 1, 2021 email alert

http://saadvisory.com/update/archive/Nov-1-2020.htm

current trading @ $27.00 (crazy) SELL Total position at open! ( OR PRE MARKET)

2 LOW FLOATERS THAT YOU COULD ROLL YOU HUGE PROFITS IN!

GIGA $3.43 RADAR AND ELETRONIC WARFARE . LOW FLOATER NASDAQ

OPP. RECENTLY AWARDED $2 MILLION ORDER. ONLY 2 MILLION SHARES OUTSTANDING. WHEN THE HERD FINDS IT! BINGO!

BKYI-$3.93 BIOMETRIC SECURITY INDUSTRY IS EXPLODING! $36 BILLION GLOBALLY SPENT IN 2020 AND ANTICIPATED TO REACH $69 BILLION BY 2025

POTENTIALLY A HUGE REWARD POTENTIAL FOR THIS EMERGING COMPANY THAT RECENT RAISED $20 MILLION WITH ONLY 8 MILLION SHARES OUTSTANDING AND NO DEBT.

$75 MILLION BACKLOG ( CHERRY ON TOP )